β-Casomorphin (1-6), bovine

CAS No. 77434-43-6

β-Casomorphin (1-6), bovine( —— )

Catalog No. M30302 CAS No. 77434-43-6

β-Casomorphin (1-6), bovine is a opioid-like bioactive peptide of β-Casomorphin.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    β-Casomorphin (1-6), bovine
  • Note
    Research use only, not for human use.
  • Brief Description
    β-Casomorphin (1-6), bovine is a opioid-like bioactive peptide of β-Casomorphin.
  • Description
    β-Casomorphin (1-6), bovine is a opioid-like bioactive peptide of β-Casomorphin.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    77434-43-6
  • Formula Weight
    676.76
  • Molecular Formula
    C35H44N6O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Sequence:{Tyr}{Pro}{Phe}{Pro}{Gly}-NH2

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Chang WH, et al. β-Casomorphin increases fat deposition in broiler chickens by modulating expression of lipid metabolism genes. Animal. 2019 Apr;13(4):777-783.
molnova catalog
related products
  • 3,5-Dihydroxyergosta...

    6-Dehydrocerevisterol is a Steroids product that can be isolated from the fruit body of Ganoderma lucidum.

  • Lucidin ω-ethyl ethe...

    Lucidin ω-ethyl ether (compound 17) is an anthraquinone metabolite isolated from the root part of Prismatomeris filamentosa with some antibacterial activity against Gram-positive and Gram-negative bacteria.

  • Remimazolam

    Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?